Health Canada

This report describes the surveillance findings gathered by the Consumer Product Safety Program (CPSP) within Health Canada. The CPSP is responsible for the administration and enforcement of the Canada Consumer Product Safety Act (CCPSA) and its regulations, as well as cosmetic-related provisions...

Health Canada develops and enforces regulations under Government of Canada legislation. The Department consults with the Canadian public, industry and other interested parties in the development of laws that protect health and safety. We also prepare guidelines and policies in order to help...

This report describes the surveillance findings gathered by the Consumer Product Safety Program (CPSP) within Health Canada. The CPSP is responsible for the administration and enforcement of the Canada Consumer Product Safety Act (CCPSA) and its regulations, as well as cosmetic-related provisions...

This report describes the surveillance findings gathered by the Consumer Product Safety Program (CPSP) within Health Canada. The CPSP is responsible for the administration and enforcement of the Canada Consumer Product Safety Act (CCPSA) and its regulations, as well as cosmetic-related provisions...

This report describes the surveillance findings gathered by the Consumer Product Safety Program (CPSP) within Health Canada. The CPSP is responsible for the administration and enforcement of the Canada Consumer Product Safety Act (CCPSA) and its regulations, as well as cosmetic-related provisions...

Health Canada, Mexico’s Consumer Protection Federal Agency (PROFECO) and the United States Consumer Product Safety Commission (CPSC) continue to value and build on our long-standing cooperative efforts as consumer product safety regulators.

Description for the 5th North America Consumer Product Safety Summit 2021 hosted virtually by Health Canada.

The Tobacco Reporting Regulations madeunder the Tobacco and Vaping Products Act incorporate by reference a number of Health Canada official methods that must be followed when dealing with the following: mainstream smoke, sidestream smoke, whole tobacco, sample preparation and toxicity testing....

A series of health-related data sets from various quantitative public opinion research studies.

A series of health-related data sets from various quantitative public opinion research studies.

Survey of long-term measurements of radon concentrations in volunteer homes from 2009 – 2011. National survey conducted by the National Radon Program covering all Health Regions.

Health Canada's Clinical Trials Database is a listing of information about phase I, II and III clinical trials in patients. The database is managed by Health Canada and provides a source of information about Canadian clinical trials involving human pharmaceutical and biological drugs. Additional...

A series of health-related data sets from various quantitative public opinion research studies.

A series of health-related data sets from various quantitative public opinion research studies.

A series of health-related data sets from various quantitative public opinion research studies.

The data extract is a series of compressed ASCII text files of the full data set contained in the Canada Vigilance Adverse Reaction Online Database. It is intended for users who are familiar with database structures and setting up their own queries. Find details on the data structure required for...

A series of health-related data sets from various quantitative public opinion research studies.

Health Canada works collaboratively with provinces and territories, as well as industry stakeholders and health care practitioners to address drug shortages and to build a more open and secure drug supply system. Important progress on a number of key initiatives has been made.

The drug supply chain is highly integrated and interdependent. All stakeholders have important roles to play when it comes to addressing drug shortages.

Drug shortages are a complex and pressing global issue with serious implications for the health and well-being of Canadians. Sudden or prolonged disruptions in the availability of a product can have serious and/or life-threatening consequences for patients. It is only through the availability...